CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 859190-859488 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T47141","span":{"begin":0,"end":298},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In vivo transplantation studies showed that systemic administration of IL-10 expressing Ad-MSCs, either by intravenous or intraperitoneal injection, during the initiation phase of disease could prevent or significantly delay the development of myelin oligodendrocyte glycoprotein (MOG)-induced EAE."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1898","span":{"begin":0,"end":298},"obj":"Epistemic_statement"}],"text":"In vivo transplantation studies showed that systemic administration of IL-10 expressing Ad-MSCs, either by intravenous or intraperitoneal injection, during the initiation phase of disease could prevent or significantly delay the development of myelin oligodendrocyte glycoprotein (MOG)-induced EAE."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T137","span":{"begin":0,"end":298},"obj":"Sentence"}],"text":"In vivo transplantation studies showed that systemic administration of IL-10 expressing Ad-MSCs, either by intravenous or intraperitoneal injection, during the initiation phase of disease could prevent or significantly delay the development of myelin oligodendrocyte glycoprotein (MOG)-induced EAE."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1746","span":{"begin":219,"end":240},"obj":"Phenotype"},{"id":"T1747","span":{"begin":294,"end":297},"obj":"Phenotype"}],"attributes":[{"id":"A1746","pred":"hp_id","subj":"T1746","obj":"http://purl.obolibrary.org/obo/HP_0001263"},{"id":"A1747","pred":"hp_id","subj":"T1747","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"In vivo transplantation studies showed that systemic administration of IL-10 expressing Ad-MSCs, either by intravenous or intraperitoneal injection, during the initiation phase of disease could prevent or significantly delay the development of myelin oligodendrocyte glycoprotein (MOG)-induced EAE."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3632","span":{"begin":244,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A3632","pred":"uberon_id","subj":"T3632","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"In vivo transplantation studies showed that systemic administration of IL-10 expressing Ad-MSCs, either by intravenous or intraperitoneal injection, during the initiation phase of disease could prevent or significantly delay the development of myelin oligodendrocyte glycoprotein (MOG)-induced EAE."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5406","span":{"begin":294,"end":297},"obj":"Disease"},{"id":"T83438","span":{"begin":294,"end":297},"obj":"Disease"}],"attributes":[{"id":"A5406","pred":"mondo_id","subj":"T5406","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A5407","pred":"mondo_id","subj":"T5406","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A5408","pred":"mondo_id","subj":"T5406","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A82055","pred":"mondo_id","subj":"T83438","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A78353","pred":"mondo_id","subj":"T83438","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A21965","pred":"mondo_id","subj":"T83438","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"}],"text":"In vivo transplantation studies showed that systemic administration of IL-10 expressing Ad-MSCs, either by intravenous or intraperitoneal injection, during the initiation phase of disease could prevent or significantly delay the development of myelin oligodendrocyte glycoprotein (MOG)-induced EAE."}